Pediatric adenoid hypertrophy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age ranges from 6 months to 14 years old, regardless of gender 2.Meet the diagnostic criteria of Western medicine for adenoid hypertrophy; 3.The children's family gave informed consent and volunteered for the test. The process of obtaining informed consent shall comply with GCP regulations
Exclusion criteria
Exclusion criteria: 1.Those who do not meet the inclusion criteria; 2.Those who have received other adenoid hypertrophy drugs treatment within 2 weeks 3.Those who are allergic to the test drug 4.People with serious primary diseases or acute attacks of infectious diseases such as heart, liver, kidney, digestive and hematopoietic systems 5.Those with severe nasal septal deviation, nasal polyps, laryngeal and tracheal diseases that cause breathing difficulties 6.Accompanied by serious complications such as pulmonary heart disease, pulmonary hypertension, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ratio of Adenoid thickness to nasopharyngeal width;Sleep snoring relief rate and relief time;nasal obstruction relief rate and relief time;Open mouth breathing relief rate and relief time; | — |
Secondary
| Measure | Time frame |
|---|---|
| runny nose relief rate;Weak and lazy speech relief rate;A dull complexion relief rate;Profuse sweating relief rate;Pharyngeal discomfort relief rate;Dizziness and headache relief rate;poor appetite relief rate;Loose stools or constipation relief rate;Combined use rate of antibiotics;cough relief rate; | — |
Countries
China
Contacts
Jiangsu Province Hospital of Chinese Medicine